Social disadvantage and technology use among adults with type 1 diabetes in Quebec: A cross‐sectional study using data from the Canadian <scp>T1D</scp> ( <scp>BETTER</scp> ) Registry
Social disadvantage is linked to lower use of insulin pumps and CGM in adults with T1D in Quebec. Public funding narrows CGM disparities, but broader equity strategies are needed.
Authors
- Rayzel Shulman (ORCID: https://orcid.org/0000-0001-9943-1529)
- Joyeuse Senga (ORCID: https://orcid.org/0000-0002-1369-5046)
- Leif E. Lovblom (ORCID: https://orcid.org/0000-0002-6774-8924)
- Justin Presseau
- Alanna Weisman (ORCID: https://orcid.org/0000-0003-3778-653X)
- RÉMI P.R. RABASA-LHORET (ORCID: https://orcid.org/0000-0003-4706-5170)
- Adhiyat Najam (ORCID: https://orcid.org/0000-0001-9759-5060)
- Christine MacGibbon
- Maman Joyce Dogba (ORCID: https://orcid.org/0000-0001-6848-525X)
- Meranda Nakhla (ORCID: https://orcid.org/0000-0001-5833-5303)
- Anne‐Sophie Brazeau (ORCID: https://orcid.org/0000-0002-2699-2920)
- Lorraine Lucille Lipscombe (ORCID: https://orcid.org/0000-0001-7412-7993)
- Holly O. Witteman (ORCID: https://orcid.org/0000-0003-4192-0682)
- Wajeeha Cheema
- Ananya Banerjee (ORCID: https://orcid.org/0000-0002-0241-929X)
- Parisa Khodabandehloo
- Patience Fakembe
Institutions
- Mount Sinai Hospital (CA)
- University Health Network (CA)
- University of Ottawa (CA)
- University of Toronto (CA)
- Lunenfeld-Tanenbaum Research Institute (CA)
- Ottawa Hospital (CA)
- Hospital for Sick Children (CA)
- McGill University Health Centre (CA)
- Diabetes Canada (CA)
- Centre hospitalier universitaire de Québec (CA)
- Public Health Ontario (CA)
- Montreal Clinical Research Institute (CA)
- Université Laval (CA)
- Ottawa Hospital Research Institute (CA)
- McGill University (CA)
- Université de Montréal (CA)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1111/dom.16426
- Citations
- 4
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 5.18
Funders
- Diabetes Action Research and Education Foundation
- Eli Lilly and Company
- Sanofi
- Diabetes Canada
- Novo Nordisk
- Canadian Institutes of Health Research